The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,433,723 in first-year total cost, median $1,757,967.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-V (J2)]5
Most frequent institutions
- BIOMIMETIX JV, LLC1
- CELLDEX THERAPEUTICS, INC.1
- CLARIX IMAGING CORPORATION1
- CONVERGENT GENOMICS, INC.1
- CURADEL, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas2R44CA195749-03A1 | CRAPO, JAMES D | BIOMIMETIX JV, LLC, CO | $2,000,000 | ZCA1 |
| 2020 | Expanded Clinical Validation & Commercial Launch of the UriSeq Platform for Bladder Cancer2R44CA200174-04 | LEVIN, TREVOR | CONVERGENT GENOMICS, INC., CA | $1,875,550 | ZCA1 |
| 2020 | Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment2R44CA206801-04 | HAN, XIAO | CLARIX IMAGING CORPORATION, IL | $1,757,967 | ZCA1 |
| 2020 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping2R44CA210820-03A1 | FRANGIONI, JOHN V | CURADEL, LLC, MA | $1,595,693 | ZCA1 |
| 2020 | Immune modulation of radiation therapy with Flt3 ligand2R44CA192435-04A1 | GUHA, CHANDANKELER, TIBOR | CELLDEX THERAPEUTICS, INC., NJ | $1,204,513 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.